PubRank

Antonella Manca

Author PubWeight™ 11.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol 2012 2.41
2 Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res 2005 0.97
3 CASC2a gene is down-regulated in endometrial cancer. Anticancer Res 2007 0.90
4 BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study. J Clin Oncol 2004 0.87
5 Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum Mutat 2004 0.86
6 Proteomic profiling of human melanoma metastatic cell line secretomes. J Proteome Res 2011 0.84
7 Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma. Cancer 2002 0.81
8 Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21. Melanoma Res 2003 0.79
9 Unexpected distribution of cKIT and BRAF mutations among southern Italian patients with sinonasal melanoma. Dermatology 2013 0.78
10 Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas. J Transl Med 2015 0.77
11 Discrepant alterations in main candidate genes among multiple primary melanomas. J Transl Med 2014 0.77
12 Mutations in ERBB4 may have a minor role in melanoma pathogenesis. J Invest Dermatol 2013 0.75